Anakinra safety experience: Infection results from a long-term safety study and postmarketing experience

被引：0
|
作者：
Veith, J
Wallis, WJ
Modafferi, D
Viveash, D
Bakker, P
Solinger, A
机构：
[1] Amgen Inc, Dev, Thousand Oaks, CA 91320 USA
[2] Amgen Inc, Med Affairs, Thousand Oaks, CA 91320 USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2003年 / 62卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：191 / 191
页数：1
相关论文
共 50 条
  • [41] Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jarskog, L.
    Jimenez-Shahed, J.
    Kumar, R.
    Ochudlo, S.
    Ondo, W.
    Fernandez, H.
    MOVEMENT DISORDERS, 2017, 32
  • [42] LONG-TERM SAFETY STUDY OF KETOPROFEN
    GOMEZ, G
    RHEUMATOLOGY AND REHABILITATION, 1976, : 85 - 86
  • [43] Long-term Efficacy and Safety of Erenumab Results From 64 Weeks of the LIBERTY Study
    Goadsby, Peter J.
    Reuter, Uwe
    Lanteri-Minet, Michel
    Paiva da Silva Lima, Gabriel
    Hours-Zesiger, Peggy
    Fernandes, Chrystel
    Wen, Shihua
    Tenenbaum, Nadia
    Kataria, Aditi
    Ferrari, Michel D.
    Klatt, Jan
    NEUROLOGY, 2021, 96 (22) : E2724 - E2735
  • [44] Long-term efficacy and safety of erenumab: Results from 64 weeks of the LIBERTY study
    Reuter, Uwe
    Goadsby, Peter J.
    Lanteri-Minet, Michel
    Hours-Zesiger, Peggy
    Fernandes, Chrystel
    Tenenbaum, Nadia
    Ferrari, Michel D.
    Klatt, Jan
    JOURNAL OF HEADACHE AND PAIN, 2019, 20
  • [45] Long-term efficacy and safety of erenumab: Results from 64 weeks of the LIBERTY study
    Reuter, Uwe
    Gaodsby, Peter J.
    Lanteri-Minet, Michel
    Hours-Zesiger, Peggy
    Fernandes, Chrystel
    Tenenbaum, Nadia
    Ferrari, Michel D.
    Klatt, Jan
    CEPHALALGIA, 2019, 39 : 10 - 11
  • [46] Safety of tacrine: Clinical trials, treatment IND, and postmarketing experience
    Gracon, SI
    Knapp, MJ
    Berghoff, WG
    Pierce, M
    DeJong, R
    Lobbestael, SJ
    Symons, J
    Dombey, SL
    Luscombe, FA
    Kraemer, D
    ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 1998, 12 (02): : 93 - 101
  • [47] Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
    Giulia Armaroli
    Ariane Klein
    Gerd Ganser
    Michael J. Ruehlmann
    Frank Dressler
    Anton Hospach
    Kirsten Minden
    Ralf Trauzeddel
    Ivan Foeldvari
    Jasmin Kuemmerle-Deschner
    Frank Weller-Heinemann
    Andreas Urban
    Gerd Horneff
    Arthritis Research & Therapy, 22
  • [48] Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry
    Armaroli, Giulia
    Klein, Ariane
    Ganser, Gerd
    Ruehlmann, Michael J.
    Dressler, Frank
    Hospach, Anton
    Minden, Kirsten
    Trauzeddel, Ralf
    Foeldvari, Ivan
    Kuemmerle-Deschner, Jasmin
    Weller-Heinemann, Frank
    Urban, Andreas
    Horneff, Gerd
    ARTHRITIS RESEARCH & THERAPY, 2020, 22 (01)
  • [49] SAFETY EXPERIENCE FROM LONG-TERM TREATMENT WITH OMEPRAZOLE (DIGESTION, VOL 51, PG 97, 1992)
    JOELSON
    DIGESTION, 1992, 53 (3-4) : 213 - 213
  • [50] Long-term safety of pirfenidone: results of the prospective, observational PASSPORT study
    Cottin, Vincent
    Koschel, Dirk
    Guenther, Andreas
    Albera, Carlo
    Azuma, Arata
    Skold, C. Magnus
    Tomassetti, Sara
    Hormel, Philip
    Stauffer, John L.
    Strombom, Indiana
    Kirchgaessler, Klaus-Uwe
    Maher, Toby M.
    ERJ OPEN RESEARCH, 2018, 4 (04)
12345